Q-omics provides the consensus-scored MIR3941 profile across patient tissues and cancer cell-line models. MIR3941 expression is associated with patient survival in 14 of 34 cancer types, with the highest sampling consensus in SKCM. Among the 18 cancer types available for tumor–normal comparison, MIR3941 is differentially expressed in 7, with the highest sampling consensus in KIRC. Additionally, MIR3941 RNA expression shows 8,847 significant protein co-abundance associations, with the highest sampling consensus in LSCC. Together, these results highlight SKCM, KIRC, and LSCC as cancer lineages where MIR3941 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR3941 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR3941 survival associations across molecular data types. MIR3941 RNA expression shows survival associations in the most cancer types (14). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR3941 RNA expression–survival associations across cancer types. High MIR3941 expression shows unfavorable associations in SKCM, STAD, THCA, ACC and UVM, but favorable associations in OV. The SKCM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify SKCM as the clearest survival context for MIR3941 RNA expression.
This table summarizes MIR3941 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 7. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for MIR3941. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR3941 shows higher tumor expression in KIRC, HNSC, STAD, KIRP, COAD and BRCA. The KIRC box plot shows higher MIR3941 RNA expression in tumor versus normal tissue (log2 FC = +0.499, t-test p < 0.001).
This table shows molecular features associated with MIR3941 in patient tissues and cancer cell lines. In patient samples, MIR3941 shows the broadest associations at the RNA and protein expression levels, with LSCC recurring as the lineage with the largest associated feature set.
